deltatrials
Completed NA INTERVENTIONAL 2-arm NCT07111312

Clinical Evaluation of a Nutraceutical Supplement (Olistic Women) for Hair Growth and Hair Loss in Human Volunteers

Placebo-controlled, Parallel, Randomized (1:1), Double-blind Study Over 6 Months to Evaluate the Efficacy and Safety of the Food Supplement Olistic Women.

Sponsor: Olistic Research Labs S.L.

Conditions Telogen Effluvium
Interventions Drinkable multifactorial food supplement containing vitamins, minerals, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women. Placebo control
Updated 2 times since 2025 Last updated: Dec 10, 2025 Started: Oct 10, 2023 Primary completion: May 10, 2024 Completion: Sep 23, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Telogen Effluvium, this trial is completed. The trial is conducted by Olistic Research Labs S.L. and has accumulated 2 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Sep 2025 – ~Jan 2026 · 4 months · monthly snapshotActive Not Recruiting~Jan 2026 – present · 6 months · monthly snapshotCompleted

Change History

2 versions recorded

  1. Jan 2026 — Present [monthly]

    Completed NA

    Status: Active Not Recruiting → Completed

  2. Sep 2025 — Jan 2026 [monthly]

    Active Not Recruiting NA

    First recorded

Oct 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Olistic Research Labs S.L.
Data source: Olistic Research Labs S.L.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations